Abstract
The purpose of this chapter is to discuss the potential role of retinoids in breast cancer chemoprevention. Chemoprevention may be defined as the use of natural substances and their synthetic analogs or of other chemicals to reduce the likelihood of cancer development. For epithelial cancers, which account for the majority of human malignancies, chemoprevention consists of intervention measures taken during the development of the neoplastic process up to the stage of in situ carcinoma. Excellent reviews [8, 32, 50] have discussed this topic since the concept and the term were introduced a decade ago [73]. However, the question of dose of chemopreventive agents in relation to the stages of tumor formation has not been adequately addressed. This issue will be specifically considered from a clinical perspective based on an overview of experimental, epidemiologic, and clinical evidence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alfthan O, Tarkkanen J, Grohn P, Heinonen E, Pyrhonen S, Saila K (1983) Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial. Eur Urol 9: 6–9
Anderson DE (1974) Genetic study of breast cancer: identification of a high risk group. Cancer 34: 1090–1097
Band PR, Besner JG, Leclaire R, Girard C, Diorio G, Deschamps M, Gelinas M, Larochelle D (1982) Phase I study of 13-cis-retinoic acid toxicity. Cancer Treat Rep 66: 1759–1761
Band PR, Deschamps M, Falardeau M, Ladouceur J, Coté J (1984) Treatment of benign breast disease with vitamin A. Prev Med 13: 549–554
Berenblum I (1982) Sequential aspects of chemical carcinogenesis: skin. In: Becker FF (ed) Cancer, vol 1. Plenum, New York, pp 451–484
Bollag W (1972) Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid). Eur J Cancer 8: 689–693
Bollag W (1974) Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice. Eur J Cancer 10: 731–737
Bollag W (1983) Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet i: 860–863
Boyd NF, O’Sullivan B, Campbell JE, Fishell E, Simon I, Cooke G, Germanson T (1982) Mammographic signs as risk factors for breast cancer. Br J Cancer 45: 185–193
Breitman TR, Selonick SE, Collins SJ (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77: 2936–2940
Brisson J, Merletti F, Sandowsky NL, Twaddle JA, Morrison AS, Cole P (1982) Mammographie features of the breast and breast cancer risk. Am J Epidemiol 115: 428–437
Chatterjee M, Banerjee MR (1982) Influence of hormones on N-(4-hydroxyphenyl)- retinamide inhibition of 7,12-dimethylbenz(a)anthracene transformation of mammary cells in organ culture. Cancer Lett 16: 239–245
Clavel F, Benhamou E, Sitruk-Ware R, Mauvais-Jarvis P, Flamant R (1985) Breast cancer and oral contraceptive: a review. Contraception 6: 553–569
Cohen SM, Wittenberg JF, Bryan GT (1976) Effect of avitaminosis A and hyper- vitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Res 36: 2334–2339
Consensus meeting (1986) Is “fibrocystic disease” of the breast precancerous. Arch Pathol Lab Med 110: 171–173
Crocker JJ, Sanders LL (1970) Influence of vitamin A and 3,7-dimethyl-2,6-octadienal (citral) on the effect of benzo(a)pyrene on the hamster trachea in organ culture. Cancer Res 30: 1312–1318.
De Wys WD, Greenwald P (1983) Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute. Semin Oncol 10: 360–364
deWaard F, Baanders-van Helewijn EA (1974) A prospective study in general practice on breast cancer risk in postmenopausal women. Int J Cancer 14: 153–160
Dickens MS, Custer RP, Sorof S (1979) Retinoid prevents mammary gland transformation by carcinogenic hydrocarbons in whole organ culture. Proc Natl Acad Sci USA 76: 5891–5895
Dion LD, Blalock JE, Gilford GE (1977) Vitamin A-induced density dependent inhibition of L-cell proliferation. J Natl Cancer Inst 58: 795–801
Dion LD, Blalock JE, Gilford GE (1978) Retinoic acid and the restoration of anchorage dependent growth to transformed mammalian cells. Exp Cell Res 117: 15–22
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312: 146–151
Dupont WD, Page DL (1987) Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125: 769–779
Farber E (1984) The multi-step nature of cancer development. Cancer Res 44: 4217– 4223
Fraker LD, Halter SA, Forbes JT (1984) Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. Cancer Res 44: 5757–5763
Fujimaki Y (1926) Formation of gastric carcinoma in albino rats fed on deficient diets. J Cancer Res 10: 469–477
Gouveia J, Hercend T, Lemaigre G, Mathé G, Gros F, Santelli G, Homasson JP, Angebault M, Lededente A, Parrot R, Gaillard JP, Bonniot JP, Marsac J, Pretet S (1982) Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid. Lancet i: 710–712
Grubbs CJ, Moon RC, Sporn MB, Newton DL (1977) Inhibition of mammary cancer by retinyl methyl ether. Cancer Res 37: 599–602
Hadjimichael OC, Boyle CA, Meigs JW (1986) Abortion before first live birth and risk of breast cancer. Br J Cancer 53: 281–284
Harisiadis L, Miller RC, Hall EJ, Borek C (1978) A vitamin A analogue inhibits radiation induced oncogenic transformation. Nature 274: 486–487
Henderson BC, Pike MC, Ross RK (1984) Epidemiology and risk factors. In: Bonadonna G (ed) Breast cancer: diagnosis and management. Wiley, Toronto, pp 15–33
Hill DL, Grubbs CJ (1982) Retinoids as chemopreventive and anticancer agents in intact animals (review). Anticancer Res 2: 111–124
Hislop TG, Coldman AJ, Elwood JM, Skippen DH, Kan L (1986) Relationship between risk factors for breast cancer and hormonal status. Int J Epidemiol 15: 469–476
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P, Strong S (1986) 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501–1546
Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281–1288
Huber PR, Geyer E, Kung W, Matter A, Torhorst J, Eppenberger U (1978) Retinoic acid-binding protein in human breast cancer and dysplasia. J Natl Cancer Inst 61: 1375–1378
Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B (1980) Risk of breast cancer in women with benign disease. J Natl Cancer Inst 65: 13–20
Jetten AR, Jetten MER (1979) Possible role of retinoic acid and binding protein in retinoid stimulation of embryonal carcinoma cell differentiation. Nature 278: 180–182
Kelsey JL, Hildreth NE (1983) Breast and gynecologic cancer epidemiology. CRC, Boca Raton, pp 5–50
Kerndrup G, Bendix-Hansen K, Pedersen B, Ellegaard J, Hokland P (1986) Primary myelodysplastic syndrome: treatment of 6 patients with 13-cis-retinoic acid. Scand J Haematol 36 (Suppl 45): 128–132
Koch HF (1978) Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Maxillofac Surg 6: 59–63
Kolonel LN, Nomura AM, Hinds MW, HirohataT, Hankin JH, Lee J (1983) Role of diet in cancer incidence in Hawaii. Cancer Res 43: 2397s-2402s
Kummet T, Moon TE, Meyskens FL (1983) Vitamin A: evidence for its preventive role in human cancer. Nutr Cancer 5: 96–106
Kung WM, Geyer E, Eppenberger U, Huber PR (1980) Quantitative estimation of cellular retinoic acid-binding protein activity in normal, dysplastic and neoplastic human breast tissue. Cancer Res 40: 4265–4269
Lane BP, Miller SL (1976) Effects of vitamin A on carcinogen induced changes in tracheal epithelial organ cultures (Abstract). Proc Am Assoc Cancer Res 17: 211
Lasnitzki I (1955) The influence of A hypervitaminosis on the effect of 20-methyl- cholanthrene on mouse prostate glands grown in vitro. Br J Cancer 9: 434–441
Lasnitzki I (1962) Hypovitaminosis A in the mouse prostate gland cultured in defined medium. Exp Cell Res 28: 40–51
Lasnitzki I (1976) Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues. Br J Cancer 34: 239–248
Leis HP (1978) Epidemiology of breast cancer: identification of high risk women. In: Gallagher HS, Lois HP, Snyderman RK, Urban JA (eds) The breast. Mosby, St Louis, pp 37–48
Lotan R (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33–91
Macklin MT (1959) Comparison of the number of breast cancer deaths observed in relatives of breast cancer patients, and the number expected on the basis of mortality rate. J Natl Cancer Inst 22: 927–951
MacMahon B, Feinleib M (1960) Breast cancer in relation to nursing and menopausal history. J Natl Cancer Inst 24: 733–753
MacMahon B, Cole P, Brown J (1972) Etiology of human breast cancer: a review. J Natl Cancer Inst 50: 21–42
McCormick DL, Moon RC (1982) Influence of delayed administration of retinyl acetate on mammary carcinogenesis. Cancer Res 42: 2639–2643
McCormick DL, Moon RC (1986) Retinoid-tamoxifen interaction in mammary cancer chemoprevention. Carcinogenesis 7: 193–196
McCormick DL, Burns FJ, Albert RE (1980) Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate. Cancer Res 40: 1140–1143
McCormick DL, Sowell ZL, Thompson CA, Moon RC (1983) Inhibition by retinoid and ovariectomy of additional malignancies in rats following surgical removal of the first mammary cancer. Cancer 51: 594–599
Mehta RG, Cerny WL, Moon RC (1983) Retinoids inhibit prolactin-induced development of the mammary gland in vitro. Carcinogenesis 4: 23–36
Merriman RL, Bertram JS (1979) Reversible inhibition by retinoids of 3-methylcholan- threne-induced neoplastic transformation in C3H/10T 1/2 clone 8 cells. Cancer Res 39: 1661–1666
Miller AB (1986) Dietary fat and the epidemiology of breast cancer. Prog Clin Biol Res 222: 17–32
Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton DL, Smith JM, Phillips SL, Henderson WR, Mullen LT, Brown CC, Sporn MB (1979) N-(4- Hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 39: 1339–1346
Moskowitz M, Gartside P, Wirman JA, McLaughlin C (1980) Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers. Radiology 134: 289–291
Munoz N, Bang LJ, Day NE, Yan WE, Yun ZC, Correa P, Wahrendorf J, Crespi M, Ji ZH, Lin LG, Fang ZS, O’Conor GT, Thurnham DI, Grassi A, Quan LY, Yao LJ, Bosch X (1985) No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomized double-blind intervention study in high risk population of China. Lancet ii: 111–114
Nettesheim P, Snyder C, Kim JCS (1979) Vitamin A and the susceptibility of respiratory tract tissues to carcinogenic insult. Environ Health Perspect 29: 89–93
Page DL, Zanderswaag RV, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61: 1055–1063
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer 55: 2698–2708
Peck GL, Gross EG, Butkus D, DiGiovanna JJ (1982) Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol 6: 815–823
Peto R, Doll R, Buckley JD, Sporn MB (1981) Can dietary β-carotene materially reduce human cancer rates? Nature 290: 201–208
Rogers AE, Herndon BJ, Newberne PM (1973) Vitamin A and dimethylhydrazine- induced colon carcinoma in the rat. Cancer Res 33: 1003–1009
Saffiotti U, Montesano R, Sellakumar AR, Borg SA (1967) Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 20: 857–864
Shroder EW, Black PH (1980) Retinoids: tumor preventers or tumor enhancers? J Natl Cancer Inst 65: 671–674
Sporn MB, Roberts AB (1983) Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034–3040
Sporn MB, Dunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs. Fed Proc 35: 1332–1338
Sporn MB, Squire RA, Brown CC, Smith JM, Wenk ML, Springer S (1977) 13–cis- Retinoic acid: inhibition of bladder carcinogenesis in the rat. Science 195: 487–489
Strickland S, Sawey MJ (1980) Studies on the effect of retinoids on the differentiation of teratocarcinoma stem cells in vitro and in vivo. Dev Biol 78: 76–85
Tabar L, Dean PB (1982) Mammographic parenchymal patterns: risk indicator for breast cancer? JAMA 247: 185–189
Thomas DB, Chu J (1986) Nutritional and endocrine factors in reproductive organ cancers: opportunities for primary prevention. J Chronic Dis 39: 1031–1050
Thompson HJ, Becci PJ, Grubbs CJ, Shealy YF, Stanek EJ, Brown CC, Sporn MB, Moon RC (1981) Inhibition of urinary bladder cancer by N-(ethyl)-all-traws-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice. Cancer Res 41: 933–936
Thompson HJ, Meeker LD, Tagliaferro AR, Becci PJ (1982) Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat. Cancer Res 42: 903–905
Threatt B, Norbeck JM, Ullman N, Kummer R, Roselle P (1980) Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer 45: 2550–2556
Todaro GJ, De Larco JE, Sporn MB (1978) Retinoids block phenotypic cell transformation produced by sarcoma growth factor. Nature 276: 272–274
Tokuhata GK (1969) Morbidity and mortality among offspring of breast cancer mothers. Am J Epidemiol 89: 139–153
Trapido EJ (1983) Age at first birth, parity and breast cancer risk. Cancer 51: 946–948
Trichopoulos D, MacMahon B, Cole P (1972) Menopause and breast cancer risk. J Natl Cancer Inst 48: 605–613
Verma AK, Boutwell RK (1977) Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res 37: 2196–2201
Waterhouse J, Muir C, Correa P, Powell J (eds) (1976) Cancer incidence in five continents, vol 3. IARC, Lyon (IARC scientific publication no 15)
Weinstein IB, Yamasaki H, Wigler M, Lee L-S, Fisher PB, Jeffrey A, Grunberger D (1979) Molecular and cellular events associated with the action of initiating carcinogens and tumor promoters. In: Griffin AC, Shaw CR (eds) Carcinogens: identification and mechanisms. Raven, New York, pp 399–418
Wellings SR, Wolfe JN (1978) Correlative studies of the histological and radiologic appearance of the breast parenchyma. Radiology 129: 299–306
Welsch CW, Brown CK, Goodrich-Smith M, Chiusano J, Moon RC (1980) Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats. Cancer Res 40: 3095–3098
Welsch CW, De Hoog JV, Scieszka KM, Aylsworth CF (1984) Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N- nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro. Cancer Res 44: 166–171
Wetherall NT, Taylor CM (1986) The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. Eur J Cancer Clin Oncol 22: 53–59
Wolbach SB, Howe PR (1925) Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 42: 753–777
Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37: 2486–2492
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Band, P.R., Coldman, A.J., Deschamps, M. (1989). Breast Cancer Risk and Chemoprevention. In: Ragaz, J., Ariel, I.M. (eds) High-Risk Breast Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73718-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-73718-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73720-6
Online ISBN: 978-3-642-73718-3
eBook Packages: Springer Book Archive